T. Rowe Price Investment Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9M | Buy |
3,996,518
+238,942
| +6% | +$2.92M | 0.03% | 397 |
|
|
2025
Q1 | $53.8M | Buy |
3,757,576
+746,264
| +25% | +$10.7M | 0.04% | 380 |
|
|
2024
Q4 | $47.9M | Buy |
3,011,312
+644,267
| +27% | +$10.3M | 0.03% | 411 |
|
|
2024
Q3 | $56.9M | Buy |
2,367,045
+149,252
| +7% | +$3.59M | 0.03% | 387 |
|
|
2024
Q2 | $44.2M | Buy |
2,217,793
+291,026
| +15% | +$5.8M | 0.03% | 402 |
|
|
2024
Q1 | $38.4M | Buy |
1,926,767
+70,899
| +4% | +$1.41M | 0.02% | 435 |
|
|
2023
Q4 | $41.6M | Buy |
1,855,868
+228,785
| +14% | +$5.13M | 0.03% | 408 |
|
|
2023
Q3 | $32.9M | Buy |
1,627,083
+117,901
| +8% | +$2.38M | 0.02% | 422 |
|
|
2023
Q2 | $38.6M | Buy |
1,509,182
+270,471
| +22% | +$6.91M | 0.03% | 408 |
|
|
2023
Q1 | $36.8M | Buy |
+1,238,711
| New | +$36.8M | 0.03% | 404 |
|